Driver mutations take the wheel in invasive yet nonmalignant disease

Area of Science:

• Gynecology
• Oncology
• Molecular Biology

Background:

• Endometriosis is a common gynecological condition characterized by endometrial tissue outside the uterus.
• Infiltrating endometriotic lesions are typically considered benign with a low risk of malignant transformation.
• However, the molecular landscape of these lesions is not fully understood.

Purpose of the Study:

• To investigate the presence and spectrum of cancer-associated mutations within infiltrating endometriotic lesions.
• To determine if molecular alterations found in cancer are present in benign endometriosis.

Main Methods:

• Genomic DNA extraction from infiltrating endometriotic lesion samples.
• Next-generation sequencing (NGS) to identify somatic mutations.
• Bioinformatic analysis to compare identified mutations with known cancer-associated mutations.

Main Results:

• Cancer-associated mutations were detected in a significant proportion of infiltrating endometriotic lesions.
• Specific mutation profiles, including those in tumor suppressor genes and oncogenes, were identified.
• The frequency and type of mutations varied among the studied lesions.

Conclusions:

• Infiltrating endometriotic lesions harbor cancer-associated mutations, challenging the notion of their complete benignity at a molecular level.
• These findings suggest a potential precursor role for endometriosis in the development of certain gynecological cancers.
• Further research is warranted to explore the clinical implications of these mutations and their role in cancer development.